{"id":44406,"date":"2021-11-30T05:03:02","date_gmt":"2021-11-30T05:03:02","guid":{"rendered":"https:\/\/dailysouthafrica.com\/?p=44406"},"modified":"2021-11-30T05:03:02","modified_gmt":"2021-11-30T05:03:02","slug":"japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron","status":"publish","type":"post","link":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/","title":{"rendered":"Japanese drugmaker Shionogi mulls developing vaccine for Omicron"},"content":{"rendered":"<div style=\"width: 75px;height: 75px;border-radius: 50%;background: url(https:\/\/nordot-res.cloudinary.com\/c_limit,w_200,h_200,f_auto,q_auto:eco\/ch\/units\/288215928582407265\/profile_2.png);background-position: center;background-size: cover;vertical-align: middle\"><\/div>\n<div style=\"margin-left: 5px;font-size: 14px;font-weight: bold;vertical-align: middle\">Published by <br \/>Kyodo News<\/div>\n<div style=\"margin-top: 10px\"><\/div>\n<p>Japanese pharmaceutical firm Shionogi &amp; Co. is considering developing a vaccine for the new Omicron variant of the novel coronavirus, one of its officials said Tuesday. The Osaka-based firm official said Shionogi has already started preparations for manufacturing active ingredients that will be used as a base to develop the vaccine for the Omicron strain, which may be highly transmissible or pose an increased risk of reinfection to people who have previously caught the coronavirus. Concerns are growing over the Omicron variant with a large number of mutations, which was first reported to the W&#8230;<!--more--><\/p>\n<p><a class=\"nordot-read-more \" target=\"_blank\" href=\"https:\/\/nordot.app\/838269453875036160?c=819177386184916992\" rel=\"noopener\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Published by Kyodo News Japanese pharmaceutical firm Shionogi &amp; Co. is considering developing a vaccine for the new Omicron variant of the novel coronavirus, one of its officials said Tuesday. The Osaka-based firm official said Shionogi has already started preparations for manufacturing active ingredients that will be used as a base to develop the vaccine &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Japanese drugmaker Shionogi mulls developing vaccine for Omicron&#8221;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":44408,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Japanese drugmaker Shionogi mulls developing vaccine for Omicron - Daily South Africa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Japanese drugmaker Shionogi mulls developing vaccine for Omicron - Daily South Africa\" \/>\n<meta property=\"og:description\" content=\"Published by Kyodo News Japanese pharmaceutical firm Shionogi &amp; Co. is considering developing a vaccine for the new Omicron variant of the novel coronavirus, one of its officials said Tuesday. The Osaka-based firm official said Shionogi has already started preparations for manufacturing active ingredients that will be used as a base to develop the vaccine &hellip; Continue reading &quot;Japanese drugmaker Shionogi mulls developing vaccine for Omicron&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\" \/>\n<meta property=\"og:site_name\" content=\"Daily South Africa\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-30T05:03:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Japanese drugmaker Shionogi mulls developing vaccine for Omicron\",\"datePublished\":\"2021-11-30T05:03:02+00:00\",\"dateModified\":\"2021-11-30T05:03:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\"},\"wordCount\":109,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg\",\"articleSection\":[\"Health Care\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\",\"url\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\",\"name\":\"Japanese drugmaker Shionogi mulls developing vaccine for Omicron - Daily South Africa\",\"isPartOf\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg\",\"datePublished\":\"2021-11-30T05:03:02+00:00\",\"dateModified\":\"2021-11-30T05:03:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage\",\"url\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg\",\"contentUrl\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg\",\"width\":600,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dailysouthafrica.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Japanese drugmaker Shionogi mulls developing vaccine for Omicron\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dailysouthafrica.com\/#website\",\"url\":\"https:\/\/dailysouthafrica.com\/\",\"name\":\"Daily South Africa\",\"description\":\"Latest News From South Africa\",\"publisher\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dailysouthafrica.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/dailysouthafrica.com\/#organization\",\"name\":\"Daily South Africa\",\"url\":\"https:\/\/dailysouthafrica.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png\",\"contentUrl\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png\",\"width\":200,\"height\":93,\"caption\":\"Daily South Africa\"},\"image\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Japanese drugmaker Shionogi mulls developing vaccine for Omicron - Daily South Africa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/","og_locale":"en_US","og_type":"article","og_title":"Japanese drugmaker Shionogi mulls developing vaccine for Omicron - Daily South Africa","og_description":"Published by Kyodo News Japanese pharmaceutical firm Shionogi &amp; Co. is considering developing a vaccine for the new Omicron variant of the novel coronavirus, one of its officials said Tuesday. The Osaka-based firm official said Shionogi has already started preparations for manufacturing active ingredients that will be used as a base to develop the vaccine &hellip; Continue reading \"Japanese drugmaker Shionogi mulls developing vaccine for Omicron\"","og_url":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/","og_site_name":"Daily South Africa","article_published_time":"2021-11-30T05:03:02+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#article","isPartOf":{"@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/"},"author":{"name":"","@id":""},"headline":"Japanese drugmaker Shionogi mulls developing vaccine for Omicron","datePublished":"2021-11-30T05:03:02+00:00","dateModified":"2021-11-30T05:03:02+00:00","mainEntityOfPage":{"@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/"},"wordCount":109,"commentCount":0,"publisher":{"@id":"https:\/\/dailysouthafrica.com\/#organization"},"image":{"@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage"},"thumbnailUrl":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg","articleSection":["Health Care"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/","url":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/","name":"Japanese drugmaker Shionogi mulls developing vaccine for Omicron - Daily South Africa","isPartOf":{"@id":"https:\/\/dailysouthafrica.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage"},"image":{"@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage"},"thumbnailUrl":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg","datePublished":"2021-11-30T05:03:02+00:00","dateModified":"2021-11-30T05:03:02+00:00","breadcrumb":{"@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#primaryimage","url":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg","contentUrl":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2021\/11\/44406-origin_1.jpg","width":600,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/dailysouthafrica.com\/japanese-drugmaker-shionogi-mulls-developing-vaccine-for-omicron\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailysouthafrica.com\/"},{"@type":"ListItem","position":2,"name":"Japanese drugmaker Shionogi mulls developing vaccine for Omicron"}]},{"@type":"WebSite","@id":"https:\/\/dailysouthafrica.com\/#website","url":"https:\/\/dailysouthafrica.com\/","name":"Daily South Africa","description":"Latest News From South Africa","publisher":{"@id":"https:\/\/dailysouthafrica.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailysouthafrica.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/dailysouthafrica.com\/#organization","name":"Daily South Africa","url":"https:\/\/dailysouthafrica.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png","contentUrl":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png","width":200,"height":93,"caption":"Daily South Africa"},"image":{"@id":"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/posts\/44406"}],"collection":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/comments?post=44406"}],"version-history":[{"count":0,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/posts\/44406\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/media\/44408"}],"wp:attachment":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/media?parent=44406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/categories?post=44406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/tags?post=44406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}